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Background: Neocentromeres are rare human chromosomal aberrations in which a new centromere has formed in
a previously non-centromeric location. We report the finding of a structurally abnormal X chromosome with a
neocentromere in a 15-year-old girl with clinical features suggestive of Turner syndrome, including short stature
and primary amenorrhea.
Result: G-banded chromosome analysis revealed a mosaic female karyotype involving two abnormal cell lines. One cell
line (84% of analyzed metaphases) had a structurally abnormal X chromosome (duplication of the long arm and
deletion of the short arm) and a normal X chromosome. The other cell line (16% of cells) exhibited monosomy X.
C-banding studies were negative for the abnormal X chromosome. FISH analysis revealed lack of hybridization of the
abnormal X chromosome with both the X centromere-specific probe and the “all human centromeres” probe, a pattern
consistent with lack of the X chromosome endogenous centromere. A FISH study using an XIST gene probe revealed
the presence of two XIST genes, one on each long arm of the iso(Xq), required for inactivation of the abnormal X
chromosome. R-banding also demonstrated inactivation of the abnormal X chromosome. An assay for centromeric
protein C (CENP-C) was positive on both the normal and the abnormal X chromosomes. The position of CENP-C in the
abnormal X chromosome defined a neocentromere, which explains its mitotic stability. The karyotype is thus designated
as 46,X,neo(X)(qter-> q12::q12-> q21.2-> neo-> q21.2-> qter)[42]/45,X[8], which is consistent with stigmata of Turner
syndrome. The mother of this patient has a normal karyotype; however, the father was not available for study.
Conclusion: To our knowledge, this is the first case of mosaic Turner syndrome involving an analphoid iso(Xq)
chromosome with a proven neocentromere among 90 previously described cases with a proven neocentromere.
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Neocentromeres are rare human chromosomal aberra-
tions that have apparently formed within interstitial
chromosomal sites that have not previously been known
to express centromere function. An acentric fragment
that would usually be lost can rescue itself by generating
a neocentromere, which functions similarly to a normal
centromere. Neocentromeres lack α-satellite DNA and
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reproduction in any medium, provided the orcentromere proteins except centromeric binding protein
(CENP-B) [1].
As summarized by Liehr et al. [2], neocentric chromo-
somes are based on a U-type exchange and the forma-
tion of inverted duplicated chromosomes [2-4] or
inverted duplications on acentric markers [5]. The
resulting marker comprises two copies of the chromo-
some segment oriented as a “mirror image” around the
breakpoint. Neocentromere formation occurs at an intersti-
tial site apparently unrelated to the site of the breakpoint.
However, the generation of the neocentromere allows the
recovery of the acentric fragment that would otherwise
have been lost and thereby restores a balanced karyotype
[6]. Extensive analysis of neocentromere formation has led
to the conclusion that neocentromere activation
occurs via an unknown epigenetic mechanism that, inal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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locus into a functional neocentromere that associates
with all of the proteins involved in active centromere
function [6]. This process has recently been described
as neocentromerization [7].
DNA polymorphism studies performed in five cases
indicated that human neocentromeres can form either
during meiosis [8,9] or mitosis [8]. Once formed, they
can also be transmitted through mitosis and meiosis
[5].
Mosaicism might be a consequence of mitotic instability
of neocentric marker chromosomes that have been
meiotically transmitted from the previous generation
[10-12]. This would be due to either suboptimal function
of the neocentric kinetochore or selection pressure against
cells containing the marker [13]. Alternatively, mosaicism
could arise from a meiotically derived marker if neo-
centromere function was not established at the time
of meiotic rearrangement. In this scenario, neocentric
function would develop after several post-fertilization
cell divisions, during which some of the markers
would be lost [14].
To date, more than 90 cases of neocentromeres involv-
ing 20 different human chromosomes have been
described [15-24], including only two cases of neocentric
X chromosome. Yu et al. reported a case with a super-
numerary neocentric marker chromosome, which con-
sisted of partial duplication of the short arm of X
chromosome in 100% of G-banded metaphases [22]. The
second case was mosaic for 45,X and 46,X,rec(Xq) withFigure 1 G-banded karyotype showing the cell line with one normal
and deletion of short arm.features of Turner syndrome [25]. We report here a
patient with features of Turner syndrome who was
mosaic for two cell lines, including 45,X and 46,X,i(Xq);
the latter contained an active neocentromere and was
monosomic for Xp and partially trisomic for Xq.
Results
Chromosome analysis of cultured lymphocytes by G-
banding revealed a mosaic female karyotype involving
two abnormal cell lines. One cell line (84% of analyzed
metaphases) had a normal X chromosome in addition to
a structurally abnormal X chromosome with duplication
of the long arm and deletion of the short arm (Figure 1).
The other cell line (16% of cells) exhibited monosomy X
(Figure 2). The proband’s mother had a normal female
karyotype, 46,XX. The father was not available for karyo-
typing. However, the abnormal X is very likely to be de
novo.
The preliminary FISH analysis revealed lack of
hybridization of the abnormal X chromosome with both
the X centromere-specific probe and the probe for all
human centromeres. This pattern was consistent with
absence of an endogenous centromere on the abnormal X
chromosome (Figures 3 and 4). This was also confirmed
by negative C-banding performed on metaphases with an
abnormal X.
Further FISH study for the XIST gene revealed that 2
copies of this gene were present on the abnormal X
chromosome (Figure 5). Moreover, the R-banding ana-
lysis revealed that the abnormal X chromosome wasand one abnormal X chromosome with duplication of long arm
Figure 2 G-banded karyotype showing a cell line with monosomy X.
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for combined whole X chromosome painting FISH and
simultaneous immunofluorescence staining using anti-
CENP-C antibody. The CENP-C assay was positive on
both the normal and abnormal X chromosomes, as indi-
cated by the whole X chromosome paint, confirming the
presence of a neocentromere in the abnormal XFigure 3 FISH image of metaphase using a pan-α-satellite
probe (green). Hybridization signals are present on all
chromosomes except the abnormal X.chromosome. The novel position of CENP-C in the
abnormal X chromosome defined a neocentromere,
which explains its mitotic stability
Discussion
The incidence of Turner syndrome is approximately 1 in
4000 female live births. Fewer than 5% of Turner syn-
drome cases are mosaic, with one cell line carrying one
normal and one abnormal X chromosome. Our case ofFigure 4 FISH image of metaphase using X-centromere probe.
The abnormal X chromosome lacks a hybridization signal.
Figure 7 Centromeric protein C (CENP-C) assay. CENP-C (red
signal) is present on all the chromosomes and defines the presence
of a neocentromere in the abnormal X.
Figure 5 FISH image of metaphase using XIST gene probe
(red). The abnormal X chromosome has two hybridization signals,
which indicates duplication of Xq.
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the presence of an isochromosome for Xq, in which a
neocentromere is present in lieu of a normal centro-
mere. The karyotype of our patient was thus designated
as 46,X,neo(X)(qter-> q12::q12> q21.2-> neo-> q21.2->
qter)[42]/45,X[8], based on the results obtained from
chromosome and FISH analysis.
This iso(Xq) essentially represents an inverted duplica-
tion of Xq, which possibly occurred at maternal meiosis
I; this inversion apparently involves anomalous or U-
type crossing over at Xq12 as described by Warburton
[4]. The duplicated copies are mirror images around theFigure 6 R-banding analysis reveals the abnormal X
chromosome to be inactive.breakpoint Xq12 (Figure 8). This acentric fragment
would usually be lost but has rescued itself by generating
a neocentromere, which functions similarly to a normal
centromere, at one of the duplicated regions. Lack of a
centromere and presence of a neocentromere in the
abnormal X chromosome of our patient was confirmed
by FISH and CENP-C staining. The novel position of
CENP-C and absence of alpha satellite DNA in the
abnormal X chromosome defined a neocentromere,
which also explains its mitotic stability. The mosaicism
observed in the karyotype of our patient is very likely a
consequence of gradual formation, stabilization, and
functioning of the neocentromere after several post-
fertilization cell divisions, during which the iso(Xq) may
be lost in a proportion of cells [14,26].
X-inactivation is the process by which most genes on
one of the two X chromosomes in females are silenced
epigenetically. In normal females cells, the choice of
which X chromosome (paternal or maternal) is to be
inactivated is a random one that is then maintained in
each clonal lineage. However, an abnormal X chromo-
some is always the inactive one if it is structurally unba-
lanced. This was confirmed in our patient by R-banding,
which showed that the abnormal X was inactivated in
all metaphases carrying this abnormal chromosome.
Presence of an XIST gene, the key master locus for X in-
activation, at band Xq13 was also confirmed by FISH:
the abnormal X chromosome carried two copies, and
the normal X carried one. The XIST gene is normally
expressed only from the inactive X and is transcription-
ally silent on the active X. The selective inactivation of
the abnormal X in our patient likely results in a protect-
ive effect from possible abnormalities attributable to it.
Figure 8 Ideogram of the neocentric X. The duplicated copies are
mirror images around the breakpoint Xq12. The neocentromeric
constriction has occurred within the band Xq21.2 of one of the
duplicated regions.
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To our knowledge, this is the first case of mosaic Turner
syndrome involving an analphoid iso(Xq) chromosome
with a proven neocentromere among 90 previously
described cases with a proven neocentromere.
Methods
Chromosome analysis
A peripheral blood sample from a 15-year-old girl was
referred to our laboratory for cytogenetic analysis. Her
clinical features were suggestive of Turner syndrome,
including short stature and primary amenorrhea. Meta-
phase chromosome preparations were obtained from the
patient and her mother according to standard procedures.
Chromosomes were analyzed with G-banding at theresolution level of 550 bands. C-banding was also per-
formed on the patient’s metaphase cells. The father was
not available for karyotyping.
Analysis by Fluorescence in situ hybridization (FISH)
FISH analyses were carried out according to the protocols
recommended by the manufacturer of the DNA probes.
This study used α-satellite DNA probes for all chromo-
some centromeres, a mixture of probes for X chromosome
centromere (DXZ1) and Y chromosome centromere
(DYZ3), a locus specific probe for XIST gene located at
Xq13 (spectrum orange)/CEP X centromere (spectrum
green) and a probe for whole chromosome painting.
Analysis by R-Banding
R-banding for evaluation of X-inactivation status was
then performed. To obtain RBA (reverse banding by
5-bromodeoxyuridine and acridine orange), the cul-
ture techniques were modified by adding 75 μg/mL
5-bromodeoxyuridine 6.5 hours before harvest, and
slides were prepared by a modification of the technique of
Van Dyke et al. [27].
Ethical approval and consent
These studies were performed on anonymized samples
received in the clinical laboratory and thus were
exempted from the requirement for consent by an opinion
for the Western Institutional Review Board.
Analysis by CENP-C staining
To investigate the presence of a neocentric marker
chromosome, immunofluorescence analysis with anti-
body to centromere protein C (CENP-C) was employed
on fresh 3:1 methanol:acetic acid fixed chromosomes
according to published protocols [18].
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